Table 3 EBV status and demographic characteristics and clinical presentations in NHL cases
EBV-DNA positive | EBV-DNA negative | p-value | |
|---|---|---|---|
Age | |||
1-4 years | 2 (40%) | 3 (60%) | 0.813 |
5-9 years | 17 (70.8%) | 7 (29.2%) | |
10-14 years | 2 (33.3%) | 4 (66.7%) | |
Sex | |||
Male | 10 (71.4%) | 4 (28.6%) | 0.22 |
Female | 11 (52.4%) | 10 (47.6%) | |
NHL subtype | |||
BL | 19 (59.4%) | 13 (40.6%) | 0.652 |
Non-BL | 2 (66.7%) | 1 (33.3%) | |
Primary anatomical site | |||
Jaw | 7 (43.8%) | 9 (56.2%) | 0.247 |
Abdomen | 12 (75%) | 4 (25%) | |
Lymph nodes | 2 (66.7%) | 1 (33.3%) | |
Clinical stage | |||
Early | 10 (52.6%) | 9 (47.4%) | 0.332 |
Late | 11 (68.6%) | 5 (31.4%) |